E3-ubiquitin ligase Cullin3 (Cul3) is a high confidence risk gene for Neurodevelopmental Disorders (NDD) including Autism Spectrum Disorder (ASD) and Developmental Delay (DD). We generated haploinsufficient Cul3 mouse model to investigate brain anatomy, behavior, molecular, cellular, and circuit-level mechanisms dysregulated by Cul3 mutations. Brain MRI of Cul3 mutant animals found profound abnormalities in half of brain regions, including decreased volume of cortical regions and increased volume of subcortical regions. Cul3 mutant mice exhibited social and cognitive deficits, and hyperactive behavior. Spatiotemporal transcriptomic and proteomic profiling of the brain implicated neurogenesis and cytoskeletal defects as key drivers of Cul3 functional impact. Cortical neurons from mutant mice had reduced dendritic length and loss of filamentous actin puncta, along with reduced spontaneous network activity. Inhibition of small GTPase RhoA, a molecular substrate of Cul3 ligase, rescued dendrite length phenotype. This study identified RhoA signaling as a potential mechanism, through which Cul3 mutation impacts early brain development.
Introduction
Rare and de novo single nucleotide variants (SNVs) and copy number variants (CNVs) are major risk factors for neurodevelopmental disorders (NDDs). E3 ubiquitin ligase Cullin 3 (Cul3) is among genes most confidently implicated in NDDs with the genome-wide significant FDR<0.01 (Sanders et al., 2015) . Exome sequencing studies have identified at least 20 mutations in the Cul3 gene (13 protein-truncating mutations and 7 SNVs) in patients with Autism Spectrum Disorder (ASD), Developmental Delay (DD) and Schizophrenia (SCZ), with no Cul3 mutations detected in healthy controls (Figure 1A, Table S1 ).
Cul3 belongs to a family of RING E3 ubiquitin ligases, and its molecular function has been well-characterized (Petroski and Deshaies, 2005) . Cul3 regulates protein turnover by interacting with different adaptor proteins and ubiquitinating and directing for proteasomal degradation a variety of substrate proteins. As Cul3 can interact with multiple adapters, it is involved in regulation of a wide range of cellular processes including cytoskeleton organization, cell cycle regulation, protein trafficking, and stress response among many others (Petroski and Deshaies, 2005) . Less is known about the function of Cul3 in neural cells, despite its increased expression during embryonic stages of brain development (Kang et al., 2011) . Notably, homozygous deletion of Cul3 in mice is lethal during early embryonic development (Singer et al., 1999) .
One of the Cul3 adapters, KCTD13, has been implicated in mental disorders. KCTD13 is located within a large (~600 kb) CNV at 16p11.2 that confers high risk for psychiatric and developmental disorders (Malhotra and Sebat, 2012) . We previously demonstrated that Cul3 is co-expressed with KCTD13, and corresponding proteins physically interact during late mid-fetal period of brain development . This interaction is crucial for regulating the levels of a small GTPase RhoA, and Cul3 knockdown leads to RhoA accumulation (Chen et al., 2009) . RhoA is involved in neuronal migration, axon growth, dendrite formation, and cytoskeleton remodeling during brain development (Govek et al., 2011) . Furthermore, upregulation of RhoA through its constitutive expression has been linked to suppression of dendritic spine morphogenesis and to dramatic loss of spines (Govek et al., 2011; Zhang and Macara, 2008) . The contribution of RhoA to local regulation of axon growth has been recently demonstrated (Walker et al., 2012) .
To investigate the impact of NDD-associated mutations on brain development, we generated Cul3 haploinsufficient (Cul3 +/-) mouse model using CRISPR/Cas9 genome engineering. We
We analyzed the anatomy of fixed 8-to 10-week old adult (N=38) and postnatal day 7 (P7) (N=41) WT and Cul3 +/mouse brains using magnetic resonance imaging (MRI) (Method Details). We observed profound brain volume abnormalities in 46% (83/182, FDR<5%) of brain regions in Cul3 +/adult mice (Figure 2A , Table S2 ). Total brain volume, as well as relative grey matter volume, were both significantly lower in Cul3 +/mice compared to WT (P<0.01 and P<0.05, respectively, two tailed t-test, Figures 2B-2C) . No differences were observed in the white matter volume between Cul3 +/and WT mice (Figure 2D) . With respect to specific brain regions, several areas of somatosensory cortex, entorhinal cortex and cerebellum were significantly decreased (Figure 2E) , and midbrain, hypothalamus and thalamus were significantly increased in mutant mice (Figure 2F) . Among other notable brain areas, many olfactory bulb regions, some of the hippocampal regions and primary visual cortex were also decreased (Table S2) . Overall, the volume of many cortical regions was decreased, whereas the volume of many subcortical regions was increased in the adult mutant mice. Similar trends in brain volume changes were found in early postnatal brain, suggesting that the impact of Cul3 mutation initiates during early brain development (Figure S1, Table S2 ).
Besides volume changes of specific brain regions, Cul3 +/mice displayed decreased cortical thickness, particularly within frontal cortical regions of the brain (Figure 2G) . To investigate what layers contributed to the observed reduced thickness, we immunostained brain sections with mature neuron marker NeuN and upper layer neurons (II-IV) BRN2 (Figure 2H) .
We observed reduction in neuron number from layers II-IV in the mutant suggesting that these layers are likely contributing to cortical thickness decrease To assess whether programmed cell death, or apoptosis, may be responsible for reduced cortical thickness, we subjected nuclei of primary cortical neurons at DIV14 to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). We observed significantly increased apoptosis in Cul3 +/mice compared to WT (P < 0.0001, t-test, Figure 2I) . These results suggest that Cul3 mutation severely impacts multiple brain regions in mice and affects cortical thickness, likely via increased apoptosis.
Cul3 mutation causes behavioral deficits in mice
Given profound changes of brain volume in Cul3 +/mice, we performed behavioral testing in adult animals to understand the impact of mutation on behavior. In the open field test, Cul3 +/mice travelled longer distances (P =0.032; t-test, Figure 3A ) with higher speed (P =0.032; t-test; Figure 3B ), suggesting hyperactivity. Data analysis in 10 min time bins revealed that they started to become more hyperactive after 20 min from the beginning of the test (Figure 3C) . To assess whether hyperactivity is related to anxiety, we measured time spent in the center of the open field arena vs periphery, and observed no differences between Cul3 +/and WT (Figure S2) . Selfgrooming that may also suggest anxiety was not increased in the mutant mice ( Figure 3D) .
To investigate learning, short-term memory, and social interaction we first used novel object recognition test. In this task, Cul3 +/mice spent shorter time exploring novel object than WT mice (P<0.05, t-test, Figure 3E ). In the social interaction test, we first measured sniffing time of novel mouse vs novel object. Cul3 +/mice spent slightly less time sniffing the mouse than WT mice, and both Cul3 +/and WT mice preferred the mouse to the object (Figure 3F) . However, when a novel mouse was introduced instead of the object, Cul3 +/mice spent the same time sniffing novel and familiar mouse, and this sniffing time was shorter compared to WT mice ( Figure  3G) . These results suggest that Cul3 +/mice are hyperactive and have impaired short-term memory and social interaction.
In addition to behavioral testing of adult mice, we investigated general developmental milestones in newborn mice through 21 days of age. There were no differences between genotypes in eye opening, ear-twitching, auditory startle, forelimbs grasping and other developmental milestones. The Cul3 +/mice demonstrated delayed performance in surface righting and cliff aversion tests, suggesting potential problems with motor control and vestibular difficulties ( Figure S3 ). However, motor control deficiency did not persist into adulthood as demonstrated by higher distance traveled by the adult mutant mice in the open field test ( Figure  3A) .
Cul3 mutation dysregulates cytoskeleton-related genes transcriptome-wide
To understand how Cul3 mutation impacts transcriptome during brain development, we performed RNA sequencing (RNA-seq) of 108 brain transcriptomes derived from three developmental periods (embryonic E17.5, early postnatal P7 and adult) and three brain regions (cortex CX, hippocampus HIP and cerebellum CB) of Cul3 +/mutant and WT mice (Figure S4-S5). Differential gene expression analyses was carried out to identify genes that were up-or down-regulated in the Cul3 +/mutant vs WT mice (Method Details). As expected, Cul3 was the most differentially expressed gene in all datasets, validating haploinsufficiency. Dosage changes of Cul3 gene also had transcriptome-wide trans-effect, dysregulating other genes. We identified hundreds of differentially expressed genes (DEG) between Cul3 +/mutant and WT mice at 10% FDR across developmental periods and brain regions (Table S3 ). In total, we identified 736, 1239 and 1350 unique DEGs in embryonic, early postnatal and adult periods, respectively. Likewise, in total we identified 727, 1641 and 1032 unique DEGs in CX, CB and HIP, respectively ( Figure  S6 ). Gene Ontology (GO) functional annotations of DEGs revealed enrichment of terms shared among multiple periods and regions that included cell adhesion, extracellular matrix organization, cell migration and motility, cell proliferation, and cilium-and microtubule-related functions ( Figure  S7 , Table S4 ). Further analyses of DEGs that were contributing to the enriched GO terms identified clusters of genes that were up-or down-regulated in specific periods or regions (Table  S5 ). GO annotation of these clusters highlighted terms shared by at least two clusters ( Figure  4A , Table S6 ). Expression patterns of DEGs across periods selected from several shared GO terms highlight integrin and cilium for embryonic, cell adhesion and migration for early postnatal, and cytoskeletal processes for adult periods (Figure 4B) .
To further investigate DEGs, we performed statistical enrichment of DEGs against curated gene lists with previous evidence for involvement in ASD (Figures 4C-4D) . We observed enrichment of early postnatal and adult period DEGs in presynaptic and postsynaptic, highly intolerant to mutations (pLI>0.99), FMRP binding target, and high confident ASD risk genes, with the latter also enriched in the embryonic period ( Figure 4C) . With regards to the regions, CB was highly enriched in postsynaptic genes, and CX was enriched in ASD risk genes, synaptic, and highly intolerant to mutations genes ( Figure 4D ). This suggests that Cul3 mutation dysregulates cytoskeletal genes, as well as genes relevant to ASD pathogenesis.
Proteomic profiling supports neuron cytoskeleton and neuron projection dysregulation
Cul3 is a part of the ubiquitin-proteasome system that has significant role in protein turnover. To investigate the impact of Cul3 on regulation of protein expression, we carried out quantitative Tandem Mass Tag mass spectrometry (TMT-MS) on 48 brain samples derived from three developmental periods (embryonic E17.5, early postnatal P7 and adult) and two brain regions (cortex CX and cerebellum CB) of Cul3 +/mutant and WT mice ( Figure S8) . In most cases, tissues for proteomics experiments were dissected from the remaining brain hemisphere of the same samples that were used for the RNA-seq profiling.
Differential protein expression analyses identified hundreds to thousands of differentially expressed proteins (DEPs) across various datasets (Table S7) . Overall, more DEPs were detected in embryonic brain than in early postnatal or adult, and more DEPs were detected in CX than in CB ( Figure S9) . For example, we identified 2,329 DEPs in embryonic, 986 in early postnatal and 402 in adult CX (FDR<15%). GO annotations pointed to dysregulation of neuronrelated and cytoskeletal functions (Figure 5A) , with intermediate filament and neuron projection shared among different periods (Table S8) . Interestingly, proteins significantly up-or downregulated in Cul3 +/mutant were both contributing to neuron projection development GO function, whereas intermediate filament proteins were all upregulated in Cul3 +/embryonic CX (Figure 5A) . Notably, three cytoskeletal proteins, neuronal intermediate filament protein (Ina), plastin (Pls3), and vimentin (Vim) were found to be upregulated in all proteomics datasets, supporting neuron cytoskeleton dysregulation by Cul3 mutation with higher confidence (Figure 5B) . We confirmed Pls3 upregulation by Western blot (Figure 5C ). In addition, several other proteins with important neuronal and developmental functions were shared among datasets. They include receptor for netrin Dcc, required for axon guidance, contactin-associated protein-like Cntnap2, and treacle ribosome biogenesis factor Tcof1, involved in embryonic development of the craniofacial complex.
Similar to DEGs, we performed enrichment analyses of DEPs with genes previously implicated in brain development and ASD. Embryonic and early postnatal developmental periods demonstrated stronger enrichment of genes from essentially all tested datasets, including ASD risk genes, compared to adult ( Figure 5D ). Likewise, cortex had stronger enrichments across all datasets than cerebellum ( Figure 5E ). This suggests that Cul3 mutation impacts proteins expressed during early cortical development.
To further investigate the impact of Cul3 on protein expression in mouse brain, we performed weighted protein co-expression network analysis (WPCNA) to identify modules of proteins with correlated expression that are impacted by the Cul3 haploinsufficiency. We identified multiple protein co-expression modules in both, cortex and cerebellum. When modules were statistically tested for association with genotype, twenty one modules in CX (9 embryonic, 5 early postnatal and 7 adult) and eleven modules in CB (8 embryonic, 1 early postnatal and 2 adult) were detected as positively or negatively associated with Cul3 +/at 15% FDR (Table S9) . GO annotations of the modules significantly associated with genotype (Table S10-S11) were in agreement with biological functions identified from DEG and DEP analyses. For example, 8pink module was upregulated in Cul3 +/embryonic CX and enriched in intermediate filament proteins (Vim, Ina, Nes) . Likewise, downregulated 2blue module was enriched in neuronal and synaptic functions (neuron projection development, neuron differentiation, regulation of trans-synaptic signaling), with many genes previously implicated in ASD found within this module (CTNNB1, DPYSL2, NRXN1, STX1B, TBR1). Several modules contained proteins associated with chromatin and histone modification functions (1turquoise and 6red in embryonic CX, and 6red in early postnatal CX), and these modules were all upregulated in the Cul3 +/mouse. Further analyses of CX ( Figure 5F ) and CB (Figure S10) modules demonstrated significant enrichment of almost all modules in postsynaptic proteins, whereas downregulated modules with neuronal and synaptic functions (2blue in embryonic CX and 10purple in early postnatal CX) were enriched in ASD risk genes. Several downregulated early postnatal CX modules with ion transport, neuron migration and neuron projection morphogenesis functions (5green, 10purple and 11greenyellow) were enriched in intolerant to mutations and constrained genes, as well as FMRP target genes ( Figure  5F ). Only one module from embryonic CX (2blue) was enriched in ASD risk genes from a largest ASD exome sequencing study (Satterstrom et al., 2020) . Spatio-temporal brain proteome analyses further confirm dysregulation of neuronal and cytoskeletal proteins by Cul3 mutation.
Cul3 +/-cortical neurons have reduced dendritic growth and network activity
The downregulated module 2blue with neuronal and synaptic functions (Figures 6A-6C ) was the only module that was significantly enriched in multiple categories of genes, including high-confident ASD risk genes ( Figure 5F ). Biological functions related to neuron projection development, neuron differentiation and trans-synaptic signaling with proteins known to be involved in dendrite and axon growth (EphA7, RAB family proteins, DPYSL2) were present in this module ( Table S10 ). In addition, cytoskeletal proteins involved in regulation of actin polymerization from Arp2/3 and WASP complexes (ARPC2, ARPC3, EVL, BAIAP2) were found in this module. Notably, 2blue module identified in embryonic CX was preserved across early postnatal and adult CX, and in embryonic CB, but not in early postnatal or adult CB (Figure 6D) . Expression level of proteins from 2blue module were decreased in Cul3 +/mice ( Figure 6E) .
To validate this module and to investigate potential neuronal defects in Cul3 +/mice, we examined neuron morphology and network activity of primary cortical neurons derived from mutant and WT animals. We calculated dendrite length and the number of neurites, along with soma size, of 14DIV neurons stained with MAP2 dendritic marker ( Figure 6F) . Tracing of MAP2positive dendrites demonstrated reduction of total dendritic length and the number of neurites in Cul3 +/compared to WT mice (P=0.001; t-test; Figures 6G-6H) . Soma size was not affected by the Cul3 mutation ( Figure 6I) .
Altered neuron morphology could impact synaptic connectivity and alter neuronal network activity. We examined network activity using multielectrode array (MEA) recordings from 8 days old cortical neurons cultured in vitro. Representative raster plots of spontaneous spike activity from these cultures are shown in Figure 6J . Analyses of spontaneous neural recordings demonstrated significantly reduced weighted mean firing rate in Cul3 +/neurons compared to WT (P=0.002, t-test; Figure 6K ). Cul3 +/neurons also had significantly reduced bursting activity (P = 0.007, t-test; Figure 6L ). Quality controls included cell imaging to ensure comparable MEA plate coverage between genotypes, and total protein quantification from each well upon completion of the experiments.
Cul3 dysregulates actin cytoskeleton and leads to loss of F-actin puncta in cortical neurons
Proteomic profiling of mouse brain points to neuronal cytoskeleton as one of the cellular structures impacted by Cul3 haploinsufficiency. Actin cytoskeleton plays an important role in neuronal growth, adhesion and migration. We found intermediate filament proteins to be upregulated across multiple DEP datasets (Figure 5B) , along with upregulated embryonic CX module 8pink containing these proteins (Table S10) . At the same time, proteins involved in actin cytoskeleton-related processes (actin filament binding, actin cytoskeleton organization, regulation of actin cytoskeleton polymerization, regulation of actin filament length) were found to be downregulated in Cul3 +/brain. Specifically, we identified significantly downregulated 7black module in the adult CX with actin cytoskeleton-related GO functions (Figures 7A-7C ).
To validate potential actin cytoskeleton defects in Cul3 +/mouse, we co-stained 21 DIV in vitro cultured mature primary cortical neurons with Phalloidin-rhodamine and mature neuron marker MAP2 to quantify filamentous actin (F-actin) ( Figure 7D) . We observed significant reduction of Phalloidin intensity in Cul3 +/mutants (Figure 7E) , as well as reduction of the number of F-actin puncta per dendrite length ( Figure 7F) . The loss of filamentous actin from spines (Figure 7D , inset) and dendrite shortening ( Figure 6G ) likely lead to defective cytoskeletal dynamics and changes in neural network activity observed in mutant mice (Figures 6J-6L ).
Cul3 haploinsufficiency leads to RhoA upregulation
One of the direct molecular substrates of Cul3 ubiquitin ligase complex is a small GTPase RhoA. Cul3 ubiquitinates RhoA and directs it for proteasomal degradation. RhoA is an important regulator of actin cytoskeleton and neuron migration. We investigated RhoA levels in the developing brain by Western blot and observed significant RhoA upregulation in mutant embryonic and adult CX ( Figure 8A) . We also tested for levels of GTP-bound active form of RhoA (RhoA-GTP) and observed its significant increase in embryonic CX, in agreement with total RhoA upregulation ( Figure 8B ).
Since RhoA regulates neuronal actin cytoskeleton remodeling and neurite outgrowth, we investigated whether RhoA inhibition rescues previously observed dendritic length phenotype (Figure 6G ). We took advantage of previously described pharmacological inhibitor of RhoA, Rhosin. Rhosin was shown to specifically block RhoA activation and induce neurite outgrowth (Shang et al., 2012) . We repeated neuron morphometric analysis and used Rhosin (Rh) or vehicle (Vh) to treat primary cortical neuronal culture from 2 DIV until 14 DIV ( Figure 8C ). We replicated decreased dendritic length phenotype in Vh-treated Cul3 +/neurons, and Rhosin treatment rescued dendritic length defects in Cul3 +/to the level indistinguishable from the WT (Figure 8D ). This suggests that RhoA upregulation in cortical neurons could be responsible for cellular, molecular and general neurodevelopmental defects observed in the Cul3 +/mutant mice.
Discussion
Loss-of-function mutations in Cul3 ubiquitin ligase are strongly associated with autism, developmental delay and schizophrenia. However, the molecular mechanism by which Cul3 haploinsufficiency causes these diseases are unknown. Since Cul3 is highly expressed in the embryonic human brain, and its expression decreases after birth, it is likely that its molecular impact is manifested during early brain development. In this study, we generated the first CRISPR/Cas9 mouse model carrying loss-of-function mutation in the same exon of Cul3 gene as ASD patient's mutation. We characterized this model using brain MRI, transcriptomic and proteomic profiling, and provide evidence implicating cytoskeletal dynamics and cortical neurogenesis along with RhoA signaling as potential mechanisms of Cul3 haploinsufficiency.
At the neuroanatomical level, we observed changes in about half of the imaged brain regions in adult Cul3 +/mutant mice suggesting profound impact of Cul3 mutation on the brain. Many cortical structures (visual, somatosensory, entorhinal cortex, dentate gyrus and cerebellar cortex) were reduced, whereas subcortical structures (midbrain, hypothalamus and thalamus) were increased in the adult mutant mice. MRI imaging of early postnatal (P7) brain indicated that these changes initiate early in development, because similar albeit subtler alterations were observed in P7 brains. These changes in brain anatomy share similarities with other autism mouse models summarized in a previous study that clustered 26 autism mouse models into three groups by correlated size changes of distinct brain regions (Ellegood et al., 2015) . Cul3 +/model is most similar to group three comprised of 16p11.2, Mecp2, and CNTNAP2 models. Comparable brain structural changes were later reported in a different 16p11.2 deletion mouse model (Pucilowska et al., 2015) , as well as in TAOK2 mouse model (Richter et al., 2018) . The similarities in brain anatomy could stem from dysregulation of the same molecular pathways that potentially involves RhoA signaling .
In addition to volumetric changes, we observed decreased cortical thickness and increased apoptosis of cortical neurons in the Cul3 +/brain. Neurons from upper layers are likely contributing to these phenotypes, given downregulation of proteins expressed in upper layer neurons (Satb2) and beta-tubulin marker protein (Tubb3) and upregulation of neuroprogenitor marker proteins (Sox2 and Nes) in the embryonic cortex of Cul3 +/mutant mice. One possibility that could explain lower number of neurons in upper layers could be delayed neuronal maturation in addition to apoptosis. Another possibility is defective migration, which is also supported by our transcriptomic analyses.
Previously developed genetic autism mouse models (SETD5, UBE3A, SHANK3, Timothy syndrome) also observed reduced neurite outgrowth, sometimes in concert with reduced synaptic connectivity (Khatri et al., 2018; Krey et al., 2013; Moore et al., 2019; Yi et al., 2016) . The iPSCderived neurons from Timothy syndrome patients also exhibited dendrite retraction phenotype (Krey et al., 2013) . Neuron morphology, and specifically dendrite length was reduced in Cul3 +/mice. Proteomic results identified module of co-expressed proteins with neuron projection development functions. Dendritic growth deficiencies in Cul3 +/neurons likely impacted synaptic connectivity and network activity, as we observed reduced firing rate and bursting activity in these neurons. RhoA is one of the proteins that controls neurite outgrowth, and RhoA upregulation was previously implicated in loss of spines and neurite retraction (Chen et al., 2009; Krey et al., 2013; Lin et al., 2015; Shang et al., 2012; Walker et al., 2012) . Thus, reduced neurite outgrowth as a result of upregulated RhoA signaling could be a shared phenotype among different autism models.
In particular, the dysregulation of cytoskeletal proteins suggests a possible mechanism underlying cellular phenotypes observed in our Cul3 haploinsufficiency model. Spatio-temporal profiling of Cul3 mouse brain converged on key biological processes involved in early brain development including extracellular matrix organization, cell adhesion, microtubule formation, neuron migration, motility and locomotion, and cilium-related functions. All these functions rely on structural cytoskeleton proteins, further emphasizing the importance of cytoskeletal integrity during neocortical development. It is likely that Cul3 impacts a multitude of cytoskeletal proteins, including those involved in intermediate filament, microtubule and actin cytoskeleton organization, remodeling, binding and regulation. Cytoskeletal proteins were impacted to various degree in all developmental periods and regions, with three upregulated proteins (Vim, Pls3 and Ina) consistently shared by all datasets. Other proteins with actin-related functions formed a module downregulated in the mutant. We experimentally confirmed loss of filamentous actin puncta in Cul3 +/neurons, providing further evidence for cytoskeletal defects. Since F-actin is known to be abundant in spines of mature neurons, its loss suggests potential loss of spines. A recent study of a conditional Cul3 mouse model reported reduced spines in prefrontal cortex-specific deletion of Cul3 in agreement with our findings (Rapanelli et al., 2019) . The same study implicated upregulation of Smyd3 histone methyltransferase in Cul3 defects, however we did not detect this protein in our proteomics experiments. Another study reported protein translation defects, and specifically upregulation eIF4G1 protein, in another Cul3 conditional model (Dong et al., 2019) . We have detected eIF4G1 in all our proteomics datasets, however it was not significantly changed in mutants vs control (Table S7) . Importantly, Vim and Pls3 were upregulated in one study (Rapanelli et al., 2019) , and Pls3 was upregulated in another study (Dong et al., 2019) in agreement with our results.
We attribute observed cytoskeletal and neuronal defects to upregulation of RhoA signaling. First, we observed RhoA upregulation in embryonic and adult cortex of Cul3 mutant mice. Second, we were able to rescue dendrite length phenotype by pharmacological inhibition of RhoA activity. Third, RhoA upregulation was found in other relevant ASD models, such as KCTD13 (Escamilla et al., 2017) . KCTD13 is an adaptor for Cul3 that regulate RhoA ubiquitination and degradation. Thus, downregulation of either KCTD13 or Cul3 are expected to upregulate the levels of RhoA. A recent study of conditional Cul3 model also observed RhoA upregulation in the cortex (Rapanelli et al., 2019) . Most importantly, RhoA is a key regulator of actin cytoskeleton remodeling, neurite outgrowth, migration and spine formation during early cortical development (Azzarelli et al., 2014) , and we observed defects in many of these pathways in Cul3 +/mouse. It is possible that Cul3 dysregulates other pathways upstream or downstream of RhoA to cause these phenotypes. This possibility could not be ruled out by our study and needs further investigation. experiments and analyses. A.B.P., P.Z., P.M-L., K.C., J.E., K.C., J.C., and D.R. performed computational data processing and analyses. M.A. and L.M.I. wrote the manuscript, with input from all co-authors. Supervision was performed by J.S., D.R., J.P.L., J.R.Y. III, A.R.M, and L.M.I.
Materials and Methods
Generation of Cul3 +/-mice using CRISPR-Cas9 genome editing
For generating Cul3 mouse model with the patient specific p.Glu246Stop (E246X) mutation (O'Roak et al. 2012 ), single-guide RNAs (sgRNA) and single stranded oligos (ssODN) were designed to create the E246X frameshift mutation. Two single guide (Sg) RNA Sg1-GGATTAATGAGGAAATAGAG Sg2-AGTAGAAGCTAGGATTAATG with little off-target specificity for Cul3 (NM 016716.5) were designed using http://crispr.mit.edu/ platform and CHOP-CHOP (https://chopchop.cbu.uib.no/). The specificity and efficiency of each sgRNA was validated using in vitroCas9 cleavage assay. Generation of transgenic lines was performed by the UCSD Moores Cancer Center Transgenic Mouse Core Facility. Briefly, microinjections consisting of SgRNA1 (0.6M of crRNA, 0.6M tracrRNA), 0.5M of ssODN and 30ng/l Cas9 protein (PNA-Bio, USA) was injected in pronuclear stage embryos in the C57BL/6N genetic background. The exon-6 specific genotyping primers Cul3-ex6-Fwd: CTGCATGAAATGTGTCTTTAACTGT and Cul3-ex6-Rev: CCACCCCACTGCTAACTAGG were used for PCR genotyping followed by Sanger sequencing. The Heterozygous Cul3 founder mouse harboring 1bp-insertion in exon6 was expanded via breeding with wild-type (WT) C57Bl/6N mice. The carrier male Cul3 +/mice were bred for at least four generations before starting any experiments to eliminate off-target effect of CRISPR. Cul3 heterozygous (Cul3 +/-) mice were viable, reached normal lifespan, and were fertile irrespective of sex.
Mouse behavioral testing
All experiments were approved by the Institutional Animal Care and Use Committees (IACUC) of the University of California San Diego. Cul3 +/and WT littermates were used for behavioral experiments. Male and female mice were group housed post-weaning, segregated by sex, with unrestricted access to food and water, and were kept on a 12 h light/12 h dark cycle. For all tests 1 hour of habituation to the room before each test was performed. Cul3 +/and their WT littermates were evaluated on the same day and by the same equipment. Testing for open field, social preference, object recognition, repetitive behavior and social behavior were conducted during the light phase (10 am-5 pm) on different days. All testing equipment was positioned inside a photo light box that have dim overhead fluorescent lighting (14 lux).
Developmental milestones. Development of reflexes and growth was evaluated as previously described (Hill et al., 2008) . Reflexes were considered to be acquired only after they had been observed for 2 consecutive days.
Open Field. The apparatus measured approximately 43 x 43 x 33 cm (width x depth x height), the center was defined as the middle 26 x 26 cm. Mice were tested in a white open field for a total of 30 minutes per animal. The behavior and time spent in center vs borders was recorded for 30 minutes by video camera. The videos were analyzed by MATLAB software and scored for 10, 20 and 30 minutes.
Novel object recognition.
On day 1 of the experiment, mice were familiarized with the training room (1 h) in their home cages. During the first day, the mice explored an empty chamber for 5 min (plastic chamber, 61x42x22 cm). On testing day, the animals were placed in the testing chamber for 1 min to re-habituate. Then two identical objects (plastic figures) were placed into the testing chamber. The mouse was placed in the chamber for 15 min to explore the objects. After a 3h delay, the mouse was placed in the testing chamber with one object identical to the previous object, and a new object with different shape, texture and color. Over a 15-min time period, the relative amount of time the animal spends exploring the new object compared to the familiar one was quantified by MATLAB software.
Repetitive behavior. Each mouse was placed in a novel test cage with no bedding or food. The animal spent a total of 20 minutes in novel test cage (10 minutes for habituation, 10 minutes for observation). The last 10 minutes of repetitive behavior was scored for the following categories: self-grooming, circling, isolation, or another unusual behavior.
Social preference test. The three-chamber test was done in a social box and grids were purchased from Harvard Apparatus (Catalog #76-0673, #76-0674). The test was performed as previously described (Qin et al., 2018) . One day before testing mice were habituated to the threechamber apparatus, and were allowed to explore the apparatus for 10min, with empty grid at each side of the chamber. A plastic dish was placed on top of each grid to prevent climbing to the top. On test day, the test mouse was then placed in the center chamber and was free to explore the chambers for 10 min in each of the following phases: the first phase two identical non-social stimuli (Red lego blocks); the second phase non-social stimulus (yellow, gray and green Lego Blocks), and a social stimulus (age and sex matched mouse); the third phase familiar mouse and a novel mouse. The familiar mouse is the same mouse used in the second phase. The chamber was cleaned with 70% ethanol between phases. The chamber time and sniffing time was scored for the intervals of 10 min. Manual (blind analysis) and automated (MATLAB Software) methods of scoring chamber time and cylinder sniffing were used.
Magnetic Resonance Imaging (MRI) of adult and early postnatal (P7) mouse brain
The cohort used for behavioral testing was subsequently used for adult brain MRI study.
Perfusion. Mice undergone behavioral testing (Cul3 +/-: 10 male, 10 female; WT: 8 male, 10 female) were anesthetized with a ketamine/xylazine mix (10mg/kg) and intracardially perfused with 30mL of 0.1 M PBS containing 10 U/mL heparin (Sigma) and 2mM ProHance (a Gadolinium contrast agent), followed by 30 mL of 4% paraformaldehyde (PFA) containing 2mM ProHance. After perfusion, mice were decapitated and skin, lower jaw, ears and cartilaginous nose tip were removed as previously described (Nieman et al., 2018; Spencer Noakes et al., 2017) . The brain within the skull was incubated in 4% PFA containing 2mM ProHance overnight at 4 degrees Celsius then transferred to 0.1M PBS containing 2mM ProHance and .02% sodium azide for at least 7 days prior to MRI scanning.
Imaging. After perfusion, a multichannel 7.0 Tesla MRI scanner (Agilent Inc., Palo Alto, CA) was used to image the brains within their skulls. Sixteen custom-built solenoid coils were used to image the brains in parallel. In order to detect volumetric changes via anatomical imaging, the following parameters were used: T2-weighted, 3-D fast spin-echo sequence, with a cylindrical acquisition of k-space, a TR of 350 ms and TEs of 12 ms per echo for 6 echoes, field-of-view equal to 20 × 20 × 25 mm3 and matrix size equal to 504 × 504 × 630 mm3. These parameters output an image with 0.040-mm isotropic voxels. The total imaging time was 14 h.
Analysis. All images were registered through iterative linear and nonlinear registrations to create a consensus average brain image. Deformation fields were computed which describe the differences between each individual and the average. The Jacobian determinants of the deformation fields were then calculated as measures of volume at each voxel (Nieman et al., 2007) . Structure volume was also calculated by warping a pre-existing classified MRI atlas onto the population atlas, which allowed for the calculation of 182 structures (Dorr et al., 2008; Steadman et al., 2014; Ullmann et al., 2013) . Multiple comparisons were controlled for using the false discovery rate (FDR) (Genovese et al., 2002) .
Young mice (P7) -56um DTI
Perfusion. For younger mice, a similar perfusion protocol was followed with minor modifications. 15ml instead of 30ml of perfusion solution was used at both stages of the intracardial perfusion. Additionally, the skin and other skull structures were not removed following decapitation to prevent possible damage to the skull and brain of the neonatal mouse.
Imaging. For younger brains, diffusion tensor imaging was used to optimize gray/white matter contrast, as brains have yet to undergo large scale myelination in development. The diffusion sequence is a 3D diffusion-weighted FSE, with TR= 270 ms, echo train length = 6, first TE = 30 ms, TE = 10 ms for the remaining 5 echoes, one average, FOV = 25 mm × 14 mm × 14 mm, and a matrix size of 450 × 250 × 250, which yielded an image with 56 μm isotropic voxels. One b=0 s/mm 2 image is acquired and 6 high b-value (b = 2147 s/mm 2 ) images were acquired at the following directions (1,1,0), (1,0,1), (0,1,1), (-1,1,0), (-1,0,1) and (0,1,-1) corresponding to (G x ,G y ,G z ). Total imaging time was ~ 14 hours.
Analysis. First, the six high b-value images were averaged together to make a high contrast image necessary for accurate image registration. Then, all average high b-value images were linearly and nonlinearly registered together to create a consensus average brain. Deformation fields, which describe the deformations needed to take each individual mouse anatomy into the consensus average space, were calculated, and the Jacobian determinant of those deformation fields were then calculated as measures of volume at each voxel. Structure volume was also calculated by warping a pre-existing classified MRI atlas onto the population atlas, which allowed for the calculation of 56 structures. Multiple comparisons were controlled for using the false discovery rate (FDR) (Genovese et al., 2002) .
To calculate the change in region-specific volumes for a larger regions such as somatosensory cortex, cerebellum and entorhinal cortex (Figure 2E) , the sum of the volumes of all sub-regions comprising each of these larger regions was calculated for each animal. Then, the mean, standard deviation, effect size and % difference were calculated for WT and Cul3+/-groups. The two tailed T-test was used for comparing the statistical differences.
Immunohistochemistry
Mice were deeply anesthetized by xylazine and ketamine and were perfused with 4% paraformaldehyde (PFA). Whole brain tissues were extracted and dehydrated in a 30% sucrose solution at 4°C overnight. The 30 μm thick brain slices were prepared using a cryostat (Leica, Germany). Slices were rinsed in 0.01 M PBS, permeabilized with 0.1%TritonX-100 in PBS and blocked in 3% FBS (with 0.1% Triton X-100) for 1 h. Primary antibody against NeuN (mouse 1:1000, Millipore, USA), BRN2 (rabbit 1:1000, cell signaling technology, USA) was added for overnight incubation at 4°C. Donkey anti-rabbit Alexa 555 and anti-mouse Alexa 488 secondary antibody (Life Technology, Camarillo, CA, USA) was added at room temperature for 2 h incubation. After PBS rinsing, DAPI was added for nuclear staining. Fluorescent images were taken on Leica SP8 confocal microscope using 10x inverted objective and quantification was done using ImageJ (NIH).
Western Blotting
The small fraction of tissue lysates prepared for mass-spectrometry experiments were used for Western Blotting. The 10-15ug of total protein from WT and Cul3 +/cerebral cortex, cerebellum or hippocampus were resolved by SDS-PAGE and transferred onto PVDF Immobilon-P membranes (Millipore). After blocking with 5% nonfat dry milk in 1X TBS with 0.1% Tween-20 (TBST) for 1h at room temperature, membranes were first probed overnight with the appropriate primary antibodies in 3% BSA in TBST, and then after 1h of incubation with corresponding host specific HRP-conjugated secondary antibody (Abcam). Membranes were developed using the EZ-ECL chemiluminescence detection kit (Denville Scientific). The following primary antibodies were used: anti-Cul3 (1:1000; Cell Signaling), anti-RhoA (1:1000; Cell Signaling), and anti-Gapdh (1:5000; Sigma Aldrich) as a loading control. Quantification was performed by densitometry with ImageJ software.
Primary cortical neuron culture
Cortices were dissected from WT and Cul3 +/mouse embryonic brains at E17.5. Cortex from each brain was cultured individually. Dissociation was initiated by incubating the dissected cortices in 1ml of Accumax (Innovative Cell Technologies Inc) for 30 min at 37degree followed by 5min incubation in 10 mg/ml DNaseI (Sigma Aldrich), the dissociated cells were gently triturated with fire-polished glass pasteur pipette to make single cell suspension, and then passed through 40-micron nylon filter to remove any non-dissociated tissue. Cells were counted with cell counter (BioRad) and 1x10 5 cells were seeded onto glass coverslip coated with 0.01 % P-L-ornithine and 5ug/mL mouse natural laminin in 24-well plates. The plating media contained Neurobasal medium, 2% B27 supplement, 10% horse serum, 1% penicillin/streptomycin, and 2 mM Lglutamine (Invitrogen). After 12 hr, media was changed to serum-free feeding media containing Neurobasal medium, 2% B27 supplement, 1% penicillin/streptomycin, and 2 mM L-glutamine. At DIV2-4, cultures were treated with 1mM Cytosine b-D-arabinofuranoside hydrochloride (Ara-C) (Sigma Aldrich) to inhibit glial cell proliferation. Cultures were maintained at 37 degree, 5% CO2. All media components were from GIBCO unless otherwise specified.
Immunocytochemistry
Coverslips containing primary cortical neurons were fixed in 4% paraformaldehyde (PFA) for 15 min and washed three times with PBS. Permeabilization and blocking was performed with 3% Bovine Serum Albumin (BSA, Sigma-Aldrich), 0.1% Triton X-100 (Sigma Aldrich) in PBS for one hour at room temperature. The coverslips were then incubated overnight at 4°C with primary antibodies diluted in solution containing 3% BSA. PBS was used to wash the primary antibodies and the coverslips were incubated with secondary antibodies in solution containing 3% BSA for 1.5 h at room temperature. The following primary antibodies were used for immunostaining: MAP2 (rabbit 1:1000, cell signaling technology); Rhodamine Phalloidin (Cytoskeleton). Alexa Fluor Dyes (Abcam) were used at 1:1000 dilution as secondary antibodies. Nuclei were visualized with DAPI (1:25000, Life Technologies). Slides were mounted using ProLong Gold antifade reagent (Invitrogen) and analyzed under a fluorescence microscope (Leica SP8). Image analysis was performed with ImageJ software
Morphological Analysis
Images were taken with Leica SP8 confocal microscope with oil-inverted 40x objective and processed and analyzed with ImageJ 1.5 software. For soma area calculation, the perimeter of the MAP2+ cell body was manually outlined and measured. For total dendrite length analysis, the simple neurite tracer plugin for ImageJ 1.5 was used. Map2 positive neurites from each neuron were traced and the dendrite length was calculated by adding individual lengths for every neuron. F-actin positive puncta on dendrites was calculated by visually counting all protrusions from a dendrite within a 15-25 mm distance starting at a secondary branch point. One to three dendritic segments were analyzed per neuron. The no of f-actin puncta was normalized by dendritic length, similar region were also used for quantification of F-actin intensity using Image J 1.5.
Pharmacological treatment of cortical neurons
For phenotype rescue experiments, cultured cortical neurons were grown in Rhosintreated neurobasal media. Rhosin (Tocris) was added to the final concentration of 10µm to the media during at 2 DIV stage. The same amount of Rhosin was added after every 4 days during all subsequent media changes. The cells were grown for 14 days, at which dendrite staining was carried out. An equivalent amount of vehicle (Dimethylsulfoxide, DMSO) was added to a final concentration of 0.001% to growth media to obtain vehicle-treated WT and Cul3 +/cortical neurons.
TUNEL Assay
We used a terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay to measure the apoptosis of the primary cortical neurons and precursor cells. The assay was performed using APO-BrdU TUNEL assay kit (Invitorgen) as described by manufacturer. In brief, primary cortical neurons were fixed with 4%PFA followed by O/N incubation in 70% ethanol at -20degree followed by PBS washing. A freshly prepared TUNEL reaction buffer (50 μL per sample) was added at 37°C incubation for 1 h. After rinsing with the rinse buffer, the Propidium Iodide(PI) was used for nuclei staining. The cells were counted by FACS, only dual positive cells i.e. PI AND BrdU-488 positive cells were used for analysis.
Multi-electrode array (MEA) recording
Primary cortical neurons from WT and Cul3 +/-E17.5 embryos were cultured on 12-well Axion Maestro multielectrode array (MEA) plates (Axion Biosystems, Atlanta, GA, USA). Each 12-well MEA plate from Axion Biosystems was coated with 100 μg/mL poly-L-ornithine and 10 μg/mL laminin for 24 h before seeding. 1.5x10 6 neurons were plated on the coated MEA plates and a half-medium change was performed every other day using neurobasal+B27 feeding medium. Spontaneous spike activity was recorded on 8 DIV. Recordings were performed at 37 °C using a Maestro MEA system and AxIS Software Spontaneous Neural Configuration (Axion Biosystems). Briefly, Spikes were detected with AxIS software using an adaptive threshold and then analyzed using Axion Biosystems' Neural Metrics Tool. Spike time stamps were exported to Neuroexplorer (Axion Biosystems) for the creation of raster plots. Bright-field images were captured to assess for cell density and electrode coverage.
RNA isolation for RNA-Seq and qPCR
Total RNA was extracted at three developmental time periods (embryonic E17.5, early postnatal (day 7) and adult (4-6weeks)) from three brain regions (cerebral cortex, hippocampus, and cerebellum) of WT and Cul3 +/mice using the QIAGEN RNAeasy isolation kit (QIAGEN) following manufacturer's instructions. RNA sequencing was performed using equal input amount of total RNA for each sample. RNA samples were ribodepleted using Ribo-Zero rRNA Removal Kit (Illumina) and library preparation was performed using the True-Seq Stranded Total RNA kit for Illumina Sequencing according to the manufacturer's instructions. Paired-end RNA sequencing (2x150bp) was performed on an Illumina HiSeq4000 to an average depth of 40M reads per sample.
For Quantitative RT-PCR (qPCR) experiments (Figure 1E) , cDNA was synthesized starting from 100ng of total RNA with the SuperScript III First-Strand Synthesis kit and oligo dT (Invitrogen). The qPCR was performed using the CFX96 Touch™ Real-Time PCR Detection System (Bio Rad) using Power SYBR Green PCR Master Mix (Applied Biosystems). GAPDH and β-actin were used as housekeeping genes for normalization. Fold change in expression was calculated using the ΔΔ Ct method. Data represented as levels of Cul3 normalized to GAPDH levels.
RNA-sequencing Data Processing Pipeline
All 108 FASTQ files (36 embryonic, 36 early postnatal and 36 adult) ( Figure S4) were run through a unified paired end RNA-Seq processing pipeline. Pipeline source code can be found on https://github.com/IakouchevaLab/CUL3. All fastqs were trimmed for adapter sequence and low base call quality (Phred score < 30 at ends) using Cutadapt (v1.14). Trimmed reads were then aligned to the GRCm38.p5 (mm10) reference genome via STAR (2.5.3a) using comprehensive gene annotations from mouse Gencode (v16). Gene-level quantifications were calculated using RSEM (v1.3). Quality control metrics were calculated using RNA-SeQC (v1.1.8), featureCounts (v1.6.), PicardTools (v2.12), and Samtools (v1.3) (Table S12, Figure S5 ).
RNA-Seq Quality Control, Normalization and Differential Gene Expression Analysis
RNA-Seq Quality Control and Normalization Expected counts were compiled from genelevel RSEM quantifications and imported into R for downstream analyses. Expressed genes were defined as genes with TPM > 0.1 in at least 80% of samples from each genotype (WT and Cul3 +/ ). A total of 17,363; 18,656; and 18,341 expressed genes from embryonic cortex, cerebellum, and hippocampus, respectively; 18,921; 18,276; and 18,396 expressed genes from early postnatal cortex, cerebellum, and hippocampus, respectively; and 18,061; 17,835; and 17,654 expressed genes from adult cortex, cerebellum, and hippocampus, respectively, were used in the downstream analysis using the mouse Gencode (v16) annotation gtf file. Only expressed genes were included into the analysis.
To account for possible batch effects, batch effect removal was performed using EDASeq R package (Risso et al., 2011) and "remove unwanted variation" (RUVs) package in RUVseq (Risso et al., 2014) . Initial normalization of count data was done using upper quartile normalization (Risso et al., 2011) , followed by RUVseq. The parameter k in RUVseq was set to the minimum value that separated the samples based on genotypes on the PCA plot (maximum k=10). RUVs with different k values ranging from 3 to 8 were used after defining groups based on genotype (i.e. WT vs Cul3 +/-). Differential gene expression analysis was performed with edgeR (Robinson et al., 2010) using the negative binomial GLM approach and by considering design matrix that includes both covariates of interest (Genotype and Gender) and the factors of unwanted variation. Genes with a false discovery rate (FDR ≤ 0.1, Benjamini-Hochberg multiple testing correction) were considered significant and used for further downstream processing and analysis.
Fisher p-value combination with metaRNASeq R package (Rau et al., 2014 ) was used detect differentially expressed genes in period-and region-wise datasets. Genes with FDR ≤ 0.1 derived from p-value combination were hieratically clustered, and GO terms were obtained from 21 clusters using gProfiler (Reimand et al., 2007) (Table S5-S6) . GO terms were subsequently hieratically clustered using log fold GO enrichment for Figure 4B .
Gene Ontology enrichment analysis
Enrichment for Gene Ontology (GO; biological process and molecular function) was performed using gProfiler R package (Reimand et al., 2007) . Background was restricted to the expressed set of genes by period (embryonic, early postnatal, adult) or region (cortex, cerebellum and hippocampus) whenever appropriate. Ordered query was used, ranking genes by FDRcorrected p-value.
Enrichment analysis of gene sets
Enrichment analyses were performed using several established, hypothesis-driven gene sets including syndromic and highly ranked (1 and 2) genes from SFARI Gene database (https://gene.sfari.org/database/gene-scoring/); pre-and post-synaptic genes from SynaptomeDB (Pirooznia et al., 2012) ; genes with loss-of-function intolerance (pLI) > 0.99 as reported by the Exome Aggregation Consortium (Karczewski et al., 2017) ; highly constrained genes (Samocha et al., 2014) ; and FMRP targets (Darnell et al., 2011) . Fisher-exact test was used to calculate the enrichment of significantly differentially expressed genes for each curated gene set. The background lists were the union of all analyzed genes. Significance values of the results were corrected for multiple hypothesis testing using Benjamini-Hochberg corrections.
Quantitative TMT-Mass Spectrometry
Sample preparation. TMT mass-spectrometry experiments were performed on the WT and Cul3 +/cerebral cortex and cerebellum at three developmental periods (embryonic, early postnatal and adult). Tissues were collected from the remaining half of hemisphere of the brains used for RNA-seq experimnets (except for embryonic and adult cerebellum), and snap-freezed in liquid nitrogen. The tissue was lysed in RIPA buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% sodium deoxycholate and 1% Triton X-100) supplemented with 1xEDTA-free complete protease inhibitor mixture (Roche) and phosphatase inhibitor cocktails-I, II (Sigma Aldrich). The lysates were centrifuged at 16,000xg at 4°C for 30min, and the supernatants were collected. Protein concentration was quantified by modified Lowry assay (DC protein assay; Bio-Rad). Lysates were subjected to methanol-chloroform precipitation, resuspended in 8M urea in 50 mM TEAB, reduced (10 mM TCEP at room temperature for 25 min) and alkylated (50 mM chloroacetamide at room temperature in the dark for 20 min). After another round of methanolchloroform precipitation, pellets were dissolved by adding 6M urea in 50 mM TEAB, and the protein concentration was estimated by BCA assay (Thermo, 23225) . LysC/Tryp (Promega, V5073) was added by 1:25 (w/w) ratio to the proteins. After 3-4 h of incubation with 850 rpm shaking at 37°C, reaction mixture was diluted with 50 mM TEAB for urea to be less than 1 M. After the o/n digestion, peptide concentration was estimated by colorimetric peptide BCA assay (Thermo, 23275), and the peptides were labelled with TMT 10-plex reagents (Thermo, 90110) for one hour, followed by 15 min quenching with hydroxylamine according to the manufacturer's protocol. Equal amounts of reaction mixtures for each channel were pooled together and dried using SpeedVac. Dried peptides were resuspended in 0.1% TFA and fractionated using Pierce™ High pH reversed-phase peptide fractionation kit (Thermo, 84868) and then dried in SpeedVac.
Mass spectrometry.
Each fraction was dissolved in buffer A (5% acetonitrile, 0.1% formic acid) and injected directly onto a 25 cm, 100μm-ID column packed with BEH 1.7μm C18 resin (Waters). Samples were separated at a flow rate of 300 nl/min on nLC1000 (Thermo). A gradient of 1-30% B (80% acetonitrile, 0.1% formic acid) over 160 min, an increase to 90% B over another 60 min and held at 90% B for a final 20min of washing was used for 240 min total run time. Column was re-equilibrated with 10μL of buffer A prior to the injection of sample. Peptides were eluted directly from the tip of the column and nanosprayed directly into the mass spectrometer Orbitrap Fusion by application of 2.8 kV voltage at the back of the column. Fusion was operated in a data dependent mode. Full MS1 scans were collected in the Orbitrap at 120K resolution. The cycle time was set to 3s, and within this 3s the most abundant ions per scan were selected for CID MS/MS in the ion trap. MS3 analysis with multi-notch isolation (SPS3) (McAlister et al., 2014) was utilized for detection of TMT reporter ions at 60K resolution. Monoisotopic precursor selection was enabled, and dynamic exclusion was used with exclusion duration of 10s.
Protein identification and quantification. Tandem mass spectra were extracted from the .raw files using Raw Converter with monoisotopic peak selection. The spectral files from all fractions were uploaded into one experiment on Integrated Proteomics Applications (IP2, Ver.6.0.5) pipeline. Proteins and peptides were searched using ProLuCID (Xu et al., 2015) and DTASelect 2.0 (Tabb et al., 2002) on IP2 against the UniProt reviewed Mus musculus protein database with reversed decoy sequences (UniProt_mouse_reviewed_contaminant_05-25-2018_reversed.fasta from IP2 standard database). Precursor mass tolerance was set to 50.0 ppm, and the search space allowed both full-and half-tryptic peptide candidates without limit to internal missed cleavage and with a fixed modification of 57.02146 on cysteine and 229.1629 on N-terminus and lysine. Peptide candidates were filtered using DTASelect parameters of -p 2 (proteins with at least two peptides are identified) -y 1 (partial tryptic end is allowed) --pfp 0.01 (protein FDR < 1%) -DM 5 (highest precursor mass error 5 ppm) -U (unique peptide only). Quantification was performed by Census (Park et al., 2008) on IP2.
Differential protein expression analysis
Proteomics data was first summarized to peptide level by adding up the intensities of constituting spectra. Quantitation results from different TMT runs were merged and normalized using the pooled samples channel which was present in all runs. For each peptide, multiple measurements from the same subject were collapsed to one measurement by taking the sum of all measurements. Batch effects from the summarized protein-level data for each dataset were removed using ComBat (Johnson et al., 2007) . The data was then log2 transformed. Differentially expressed proteins were identified using function lmFit in limma (Ritchie et al., 2015) followed by eBayes moderation of standard errors (Phipson et al., 2016) . Resulting P-values were FDRcorrected using the Benjamini-Hochberg method to control for multiple comparisons.
Weighted protein co-expression network analysis
We used Weighted Gene Co-expression Network Analysis (WGCNA) (Zhang and Horvath, 2005) to define modules of co-expressed proteins from proteomics data. Proteomics data was first summarized to protein level by adding up the channel intensities of constituting peptides for each of six datasets derived from two brain regions (cortex and cerebellum) and three developmental periods (embryonic, early postnatal and adult). Batch effects from the summarized protein-level data for each dataset were removed using ComBat (Johnson et al., 2007) , followed by log2 transformation. Modules were estimated using the blockwiseModules function with the following parameters: corType=bicorr; networkType=signed; pamRespectsDendro=F; mergeCutHeight=0.1. Some parameters were specific to each dataset. For embryonic cortex: power=18; deepSplit=0; minModuleSize=100; for early postnatal cortex: power=18; deepSplit=0; minModuleSize=100; for adult cortex: power=18; deepSplit=0; minModuleSize=20; for embryonic cerebellum: power=22; deepSplit=0; minModuleSize=40; for early postnatal cerebellum: power=26; deepSplit=0; minModuleSize=150; and for adult cortex: power=12; deepSplit=2; minModuleSize=40. Module eigengene-genotype associations were calculated using linear regression model. Significance p-values were FDR-corrected to account for multiple comparisons. Genes within each module were prioritized based on their module membership (kME), defined as correlation to the module eigengene. Module preservation (Figure 6D) was tested using the "Module Preservation" function from WGCNA.
Quantification and statistical analysis
The statistical analyses for above experiments were performed using Prism software (GraphPad). Statistical tests used and exact values of n are described in Figure legends . Significance was defined as p < 0.05(*), p < 0.01(**), or p < 0.001(***). Blinded measurements were performed for any comparison between control and Cul3 +/genotypes. showing its significant reduction in Cul3 +/mutant mice cortex (p<0.01; n=6 for each genotype); hippocampus (p<0.001; n=6 for each genotype) and cerebellum (p<0.001; n=6 for each genotype); Error bars represents meanSD. Two tailed T-test was used for calculating statistical significance for D-F. Dots represents independent mice.
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Figure 2. Cul3 +/mice have altered brain morphology. (A)
Voxel-wise analysis highlighting significant differences in relative volumes throughout the brain between WT and Cul3 +/mice with 5% false discovery rate (FDR). Scale bar 2.7-10.7 indicates decreasing FDR, where 2.7=5% FDR. Red color signifies increased and blue color signifies decreased brain volume compared with WT brain. (B) Cul3 +/mice have reduced absolute brain volume (**p<0.01) compared to WT mice (WT n=18, Cul3 +/-n=20). (C) Reduced relative gray matter volume in Cul3 +/mouse brain (*p<0.05).
(D)
No significance difference is observed in relative white matter volume. (E) MRI revealed significant reduction in relative volume, normalized by absolute volume, of primary somatosensory cortex (*p<0.05); entorhinal cortex (***p<0.001); cerebellum (**p<0.01). (F) Increase in relative volume of midbrain (***p<0.001); hypothalamus (***p<0.001); thalamus (***p<0.001; WT n=18, Cul3 +/-n= 20). (G) Reduced cortical thickness is observed by MRI in Cul3 +/mice. (H) Reduced cortical thickness of somatosensory cortex in Cul3 +/mice, left panel shows somatosensory cortex region stained with NeuN (mature neuron marker) and BRN2 (layer II-IV marker); reduction of total cortical thickness and density of NeuN and BRN2 positive cells/area in layer II-IV are observed (*p<0.05; two tailed T-test, n=6 for each genotype). (I) Increased apoptosis in Cul3 +/mice as measured by TUNEL assay on 14DIV primary cortical neurons, the dual positive neurons for PI and BrdU-488 were counted by flow cytometry; (Q4) were considered as apoptotic cells containing BrdU-488/PI+ cells (***p<0.001; n=9 for each genotype). Dots represent independent samples; Two tailed T-test used for B-I; error bars represent mean ± SD. preference for novel object in novel object recognition test (*p<0.05; Two tailed T-test, WT n=18; Cul3 +/-n=20). (F) (Upper panel) Schematic diagram of three chamber social interaction test; reduced sniffing time is observed for Cul3 +/mice while interacting with a novel mouse (vs novel object) as compared to WT mice (WT n=17; Cul3 +/-n=19; *p<0.05; One way ANOVA). (G) Reduced sniffing time is observed for Cul3 +/mice while interacting with a novel mouse (vs familiar mouse) as compared to WT mice (WT n=17; Cul3 +/-n=19) ***p<0.01; One way ANOVA. Dots represent independent animals; error bars represent mean ± SD. mutation. (A) Heatmap of Gene Ontology terms. Fisher pvalue combination analysis was applied to identify 21 clusters of differentially expressed genes impacted by Cul3 mutation across developmental periods and brain regions. Biological processes impacting more than one cluster are shown. (B) Heatmap of genes associated with GO terms from panel (A). Genes from Integrin binding and Cilium-related GO terms are differential expressed in embryonic period, genes from cell adhesion and migration GO terms are differentially expressed in early postnatal period, and genes from cytoskeleton-related GO terms are differentially expressed in adult period. (C) Enrichment of differentially expressed genes from each period with literature-curated gene lists with previous evidence for involvement in autism. These lists include pre-and post-synaptic genes from SynaptomeDB; syndromic and highly ranked (1 and 2) genes from SFARI Gene database (https://gene.sfari.org/database/genescoring/); genes with probability of loss-of-function intolerance (pLI)>0.99 as reported by the Exome Aggregation Consortium; constrained genes; and FMRP target genes. Number of overlapped genes (in parenthesis) and odds ratio are indicated inside each cell, and provided only for FDR<0.05 and OR>1. (D) Enrichment of differentially expressed genes from each brain region with literature-curated gene lists with previous evidence for involvement in autism. See description of lists above. 
Supplementary Figures titles and legends
Figure S1. Altered brain morphology of Cul3 +/postnatal day 7 (P7) mice. (A) Voxel-wise analysis highlighting significant differences in relative volumes throughout the brain between WT and Cul3 +/mice with 5% false discovery rate (FDR). Scale bar 2-4.9 indicates decreasing FDR, where 2 corresponds to 5% FDR and positive or negative change compared with WT brain. (B) Cul3 +/mice have reduced absolute brain volume (***p<0.001) compared with WT mice (n=22 WT, 19 Cul3 +/-). (C) MRI revealed significant increase in hypothalamus volume (***p<0.001). (D-F) MRI revealed significant reduction in relative volume (normalized by % total brain volume) of cerebellum (*p<0.05), parieto-temporal cortex (*p<0.05), and frontal cortex (*p<0.05); Dots represent individual samples; Two tailed T-test used for B-F; error bars represent mean ± SD. . (B) The righting reflex is motor ability for a mouse pup to be able to flip onto its feet from a supine position, Cul3 +/mice display delayed righting reflex as compared to WT mice (n=17 WT, n=19 Cul3 +/-, p<0.01). (C) Cul3 +/mice display significant vestibular imbalance. The pup's eyes are still closed so fear is not the driving factor to turn away from the cliff's edge (n=15 WT, n=20 Cul3 +/-*, p<0.05). 
Figure S8. TMT quantitative proteomics experimental design and data analysis workflow.
A total of 48 proteomes (24 each for Cortex and Cerebellum) have been processed in this study by TMT 10-plex labeling followed by LC-MS/MS. Protein Quantification was carried out by Census. Quality control including principal component analyses, ComBat has been performed. LIMMA was implemented for differential protein expression analyses. Figure S10 . Protein co-expression modules in Cul3 +/cerebellum. Hierarchical clustering of protein co-expression modules by module eigengene for Cul3 +/cerebellum. Module-genotype associations (*FDR<0.1) are shown below each module. A total of 8, 1, and 2 modules were significantly associated with Cul3 +/genotype in embryonic, early postnatal and adult cerebellum, respectively. Module enrichment analyses against literature-curated gene lists with previous evidence for involvement in autism are shown at the bottom (* FDR<0.05). Table S1 . Cul3 mutational spectrum. Table S2 . Brain MRI of Cul3 +/adult and early postnatal mouse brain. Table S3 . Differentially expressed genes (DEGs) in embryonic, early postnatal and adult cortex, hippocampus and cerebellum. Table S9 . Module membership from protein co-expression (WPCNA) analysis in embryonic, early postnatal and adult cortex and cerebellum. Table S10 . Gene Ontology enrichment analysis of protein co-expression modules from WCPNA of cortex .   Table S11 . Gene Ontology enrichment analysis of protein co-expression modules from WCPNA of cerebellum .   Table S12 . RNA-seq parameters and quality control metrics from Cutadapt, STAR, Picard, and RNA-SeQC for embryonic E17.5, early postnatal P7, and adult brain representing 108 transcriptomes. B   M2  M4  M7  M9  M1  M6  M8  M5  M3  M11  M10  M12  M14  M15  M12  M24  M10  M21  M17  M23  M5  M14  M6  M26  M15  M34  M19  M29  M30  M7  M18  M4  M16  M28  M1  M3  M9  M11  M20  M22  M1  M10  M11  M4  M2 
Supplementary Tables titles
